Bad Drugs Are Looking Good - Reevaluating Controlled Substances for Medical Treatment

Explore the evolving perspectives on controversial substances in this 48-minute talk from The Aspen Institute. Delve into the groundbreaking research challenging traditional views on drugs like ketamine, psychedelics, and marijuana. Discover how these substances, once primarily associated with risks, are now being investigated for their potential therapeutic benefits. Learn about ketamine's promising role in depression treatment, the use of psychedelics in addressing addiction and PTSD, and the changing legal landscape surrounding medical marijuana. Gain insights into the complex interplay between the dangers and potential medical applications of these drugs, and understand how researchers are reevaluating their treatment value in light of new scientific findings.